Waldum H, Slupphaug G
Front Oncol. 2024; 14:1369907.
PMID: 38660133
PMC: 11040596.
DOI: 10.3389/fonc.2024.1369907.
Waldum H, Fossmark R
Int J Mol Sci. 2023; 24(17).
PMID: 37686307
PMC: 10487643.
DOI: 10.3390/ijms241713503.
Waldum H, Mjones P
Cancers (Basel). 2020; 12(11).
PMID: 33266504
PMC: 7700139.
DOI: 10.3390/cancers12113477.
Waldum H, Mjones P
Int J Mol Sci. 2020; 21(16).
PMID: 32796591
PMC: 7461029.
DOI: 10.3390/ijms21165751.
Waldum H, Sordal O, Mjones P
Int J Mol Sci. 2019; 20(10).
PMID: 31108898
PMC: 6567877.
DOI: 10.3390/ijms20102444.
Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence.
Cheung K, Leung W
Therap Adv Gastroenterol. 2019; 12:1756284819834511.
PMID: 30886648
PMC: 6415482.
DOI: 10.1177/1756284819834511.
Not only stem cells, but also mature cells, particularly neuroendocrine cells, may develop into tumours: time for a paradigm shift.
Waldum H, Oberg K, Sordal O, Sandvik A, Gustafsson B, Mjones P
Therap Adv Gastroenterol. 2018; 11:1756284818775054.
PMID: 29872453
PMC: 5974566.
DOI: 10.1177/1756284818775054.
Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.
Mjones P, Nordrum I, Sordal O, Sagatun L, Fossmark R, Sandvik A
Horm Cancer. 2017; 9(1):40-54.
PMID: 28980157
PMC: 5775387.
DOI: 10.1007/s12672-017-0311-8.
Classification of tumours.
Waldum H, Sandvik A, Brenna E, Fossmark R, Qvigstad G, Soga J
J Exp Clin Cancer Res. 2008; 27:70.
PMID: 19014574
PMC: 2596779.
DOI: 10.1186/1756-9966-27-70.
Endocrine cells in gastric carcinoma and adjacent mucosa. An immunohistochemical and ultrastructural study.
Tzaneva M
Histochem J. 2002; 34(3-4):173-80.
PMID: 12495224
DOI: 10.1023/a:1020998616007.
Ductal and acinar differentiation in pancreatic endocrine tumors.
Kamisawa T, Tu Y, Egawa N, Ishiwata J, Tsuruta K, Okamoto A
Dig Dis Sci. 2002; 47(10):2254-61.
PMID: 12395898
DOI: 10.1023/a:1020139328215.
Composite carcinoid-adenocarcinoma tumor of the stomach: report of a case.
Nagaoka S, Toyoshima H, Bandoh T, Isoyama T, Kasahara D, Kusafuka K
Surg Today. 1996; 26(3):184-8.
PMID: 8845611
DOI: 10.1007/BF00311504.
Carcinomas of the colon with multidirectional differentiation. Report of two cases and review of the literature.
Novello P, Duvillard P, Grandjouan S, Elias D, Rougier P, Bognel C
Dig Dis Sci. 1995; 40(1):100-6.
PMID: 7821094
DOI: 10.1007/BF02063950.
The prevalence and clinical significance of chromogranin A and secretogranin II immunoreactivity in colorectal adenocarcinomas.
Ferrero S, Buffa R, Pruneri G, Siccardi A, Pelagi M, Lee A
Virchows Arch. 1995; 426(6):587-92.
PMID: 7655739
DOI: 10.1007/BF00192113.
Glicentin-containing cells in intestinal metaplasia, adenoma and carcinoma of the stomach.
Ito H, Yokozaki H, Hata J, Mandai K, Tahara E
Virchows Arch A Pathol Anat Histopathol. 1984; 404(1):17-29.
PMID: 6433545
DOI: 10.1007/BF00704247.
Renin in renal cell carcinoma--an immunocytochemical study using an antibody to pure human renin.
Lindop G, Fleming S
J Clin Pathol. 1984; 37(1):27-31.
PMID: 6368597
PMC: 498613.
DOI: 10.1136/jcp.37.1.27.
Argyrophil cells in normal, hyperplastic, and neoplastic endometrium.
Sivridis E, Buckley C, Fox H
J Clin Pathol. 1984; 37(4):378-81.
PMID: 6200507
PMC: 498737.
DOI: 10.1136/jcp.37.4.378.
Argyrophil cells in early gastric carcinoma: an immunohistochemical and ultrastructural study.
Tahara E, Ito H, Shimamoto F, Taniyama K, Iwamoto T, Sumiyoshi H
J Cancer Res Clin Oncol. 1982; 103(2):187-202.
PMID: 6178741
DOI: 10.1007/BF00409648.
Gastric carcinomas with argyrophil and argentaffin cells.
PROKS C, Feit V
Virchows Arch A Pathol Anat Histol. 1982; 395(2):201-6.
PMID: 6125052
DOI: 10.1007/BF00429612.
Argentaffin and non-argentaffin carcinoid tumorurs of the appendix.
Dische F
J Clin Pathol. 1968; 21(1):60-6.
PMID: 5697337
PMC: 473665.
DOI: 10.1136/jcp.21.1.60.
